Veeva Systems Inc. (NYSE:VEEV) Shares Bought by HF Advisory Group LLC

HF Advisory Group LLC lifted its holdings in Veeva Systems Inc. (NYSE:VEEV) by 26.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,730 shares of the technology company’s stock after acquiring an additional 574 shares during the quarter. HF Advisory Group LLC’s holdings in Veeva Systems were worth $526,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Sequoia Financial Advisors LLC boosted its holdings in shares of Veeva Systems by 703.8% in the fourth quarter. Sequoia Financial Advisors LLC now owns 15,594 shares of the technology company’s stock worth $3,002,000 after buying an additional 13,654 shares during the period. Nordea Investment Management AB boosted its holdings in shares of Veeva Systems by 5.2% in the fourth quarter. Nordea Investment Management AB now owns 163,247 shares of the technology company’s stock worth $31,730,000 after buying an additional 8,007 shares during the period. ICICI Prudential Asset Management Co Ltd boosted its holdings in shares of Veeva Systems by 13.1% in the fourth quarter. ICICI Prudential Asset Management Co Ltd now owns 49,140 shares of the technology company’s stock worth $9,460,000 after buying an additional 5,674 shares during the period. Lecap Asset Management Ltd. acquired a new position in shares of Veeva Systems in the fourth quarter worth about $2,668,000. Finally, DekaBank Deutsche Girozentrale boosted its holdings in shares of Veeva Systems by 26.3% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 98,377 shares of the technology company’s stock worth $18,953,000 after buying an additional 20,488 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Activity

In related news, SVP Jonathan Faddis sold 3,598 shares of the business’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $207.42, for a total transaction of $746,297.16. Following the transaction, the senior vice president now owns 10,668 shares of the company’s stock, valued at $2,212,756.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Timothy S. Cabral sold 15,000 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $226.04, for a total value of $3,390,600.00. Following the sale, the director now owns 23,391 shares in the company, valued at approximately $5,287,301.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan Faddis sold 3,598 shares of the business’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $207.42, for a total transaction of $746,297.16. Following the completion of the sale, the senior vice president now owns 10,668 shares in the company, valued at approximately $2,212,756.56. The disclosure for this sale can be found here. Insiders have sold a total of 19,836 shares of company stock valued at $4,396,902 over the last 90 days. 10.98% of the stock is currently owned by company insiders.

Veeva Systems Stock Up 0.5 %

Shares of NYSE:VEEV traded up $1.01 during trading on Thursday, reaching $200.21. The stock had a trading volume of 106,311 shares, compared to its average volume of 977,976. Veeva Systems Inc. has a 52 week low of $160.21 and a 52 week high of $236.90. The firm has a market capitalization of $32.30 billion, a price-to-earnings ratio of 61.86, a P/E/G ratio of 2.02 and a beta of 0.74. The stock has a fifty day simple moving average of $221.86 and a two-hundred day simple moving average of $202.84.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Thursday, February 29th. The technology company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.81 by $0.11. Veeva Systems had a net margin of 22.24% and a return on equity of 11.26%. The company had revenue of $630.62 million for the quarter, compared to analyst estimates of $620.75 million. On average, analysts forecast that Veeva Systems Inc. will post 4.11 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Robert W. Baird raised their target price on shares of Veeva Systems from $245.00 to $251.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Raymond James restated an “outperform” rating and set a $260.00 price target on shares of Veeva Systems in a report on Tuesday, March 26th. KeyCorp raised their price target on shares of Veeva Systems from $232.00 to $250.00 and gave the stock an “overweight” rating in a report on Tuesday, March 5th. The Goldman Sachs Group raised their price target on shares of Veeva Systems from $219.00 to $248.00 and gave the stock a “buy” rating in a report on Friday, March 1st. Finally, Needham & Company LLC restated a “buy” rating and set a $260.00 price target on shares of Veeva Systems in a report on Tuesday, April 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $234.90.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.